Fei Liu
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Nephrology top 1%
Papers in
-
- RNA modifications and cancer 16
- Co-authors
- Inge Grundke‐Iqbal (4 shared papers)Daniel J. Tschumperlin (5 shared papers)Khalid Iqbal (4 shared papers)Cheng-Xin Gong (1 shared paper)Gerald W. Hart (1 shared paper)Inder M. Verma (4 shared papers)Andrew M. Tager (2 shared papers)Justin D. Mih (2 shared papers)
- Journals
- Medicine (10 papers)Frontiers in Pharmacology (10 papers)PLoS ONE (8 papers)Scientific Reports (7 papers)International Journal of Biological Macromolecules (7 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Fei Liu
730 papers receiving 16.9k citations
Fei Liu's Hit Papers
Peers
Comparison fields: 5 of 201
- Cancer Research 1.9k
- Nephrology 581
- Hepatology 593
- Molecular Biology 5.6k
- Immunology 1.6k
Countries citing papers authored by Fei Liu
This map shows the geographic impact of Fei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Liu more than expected).
Fields of papers citing papers by Fei Liu
This network shows the impact of papers produced by Fei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Liu. The network helps show where Fei Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 771 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease Hit paper breakdown → | 2004 | 626 |
| 2 | Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression Hit paper breakdown → | 2010 | 615 |
| 3 | Exosomal miR-146a Contributes to the Enhanced Therapeutic Efficacy of Interleukin-1β-Primed Mesenchymal Stem Cells Against Sepsis Hit paper breakdown → | 2017 | 390 |
| 4 | 2012 | 342 | |
| 5 | Activatable NIR Fluorescence/MRI Bimodal Probes for in Vivo Imaging by Enzyme-Mediated Fluorogenic Reaction and Self-Assembly Hit paper breakdown → | 2019 | 339 |
| 6 | 2018 | 223 | |
| 7 | 1999 | 208 | |
| 8 | 2012 | 204 | |
| 9 | 2008 | 201 | |
| 10 | 2018 | 201 | |
| 11 | Comparison of machine learning and logistic regression models in predicting acute kidney injury: A systematic review and meta-analysis Hit paper breakdown → | 2021 | 186 |
| 12 | 2007 | 172 | |
| 13 | 2017 | 159 | |
| 14 | 2013 | 145 | |
| 15 | 2009 | 131 | |
| 16 | 2012 | 129 | |
| 17 | 2019 | 123 | |
| 18 | 2013 | 122 | |
| 19 | 2010 | 120 | |
| 20 | 2020 | 120 |
About Fei Liu
Fei Liu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Oncology, having authored 771 papers that have together received 17.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (36 papers), Renal Diseases and Glomerulopathies (25 papers), Cancer-related molecular mechanisms research (21 papers), Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Autophagy in Disease and Therapy (17 papers), Chronic Kidney Disease and Diabetes (17 papers), Spine and Intervertebral Disc Pathology (16 papers) and RNA modifications and cancer (16 papers). The work is most often cited by research in Cancer Research (1.9k citations), Nephrology (581 citations), Hepatology (593 citations), Molecular Biology (5.6k citations) and Immunology (1.6k citations). Fei Liu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Inge Grundke‐Iqbal, Daniel J. Tschumperlin, Khalid Iqbal, Cheng-Xin Gong, Gerald W. Hart, Inder M. Verma, Andrew M. Tager, Justin D. Mih, Barry S. Shea and Asma Sharif. Their work appears in journals such as Medicine, Frontiers in Pharmacology, PLoS ONE, Scientific Reports and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.